GB9814989D0 - Gene therapy method - Google Patents
Gene therapy methodInfo
- Publication number
- GB9814989D0 GB9814989D0 GBGB9814989.1A GB9814989A GB9814989D0 GB 9814989 D0 GB9814989 D0 GB 9814989D0 GB 9814989 A GB9814989 A GB 9814989A GB 9814989 D0 GB9814989 D0 GB 9814989D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- gene therapy
- therapy method
- gene
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (24)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9814989.1A GB9814989D0 (en) | 1998-07-11 | 1998-07-11 | Gene therapy method |
CA002336805A CA2336805A1 (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of nab1 and nab2 |
NZ509174A NZ509174A (en) | 1998-07-11 | 1999-07-09 | Use of polynucleotides encoding NAB1 and NAB2 in wound healing |
KR1020017000413A KR20010071832A (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical Uses of NAB1 and NAB2 |
IDW20010345A ID27742A (en) | 1998-07-11 | 1999-07-09 | PHARMACEUTICAL USE OF NAB1 AND NAB2 |
IL14053399A IL140533A0 (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of nab1 and nab2 |
JP2000559235A JP2002520020A (en) | 1998-07-11 | 1999-07-09 | Use of NAB1 and NAB2 as drugs |
AU47914/99A AU763713B2 (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of NAB1 and NAB2 |
EA200100028A EA200100028A1 (en) | 1998-07-11 | 1999-07-09 | PHARMACEUTICAL APPLICATIONS NAB1 AND NAB2 |
HU0102835A HUP0102835A3 (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of nab1 and nab2 |
PCT/GB1999/002199 WO2000003014A1 (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of nab1 and nab2 |
BR9912018-6A BR9912018A (en) | 1998-07-11 | 1999-07-09 | Use of a nucleic acid molecule, nucleic acid molecule, pharmaceutical composition, method of treating cell proliferation disorders associated with wound healing in a mammal, including humans, and use of a nab1 or nab2 polypeptide |
EEP200100020A EE200100020A (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical Use of NAB1 and NAB2 |
APAP/P/2001/002038A AP2001002038A0 (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of NAB1 and NAB2. |
PL99345507A PL345507A1 (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of nab1 and nab2 |
YU1901A YU1901A (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses for nab1 and nab2 |
EP99931378A EP1097200A1 (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of nab1 and nab2 |
CN99810616A CN1317045A (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of NAB1 and NAB2 |
SK38-2001A SK382001A3 (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of nab1 and nab2 |
TR2001/00622T TR200100622T2 (en) | 1998-07-11 | 1999-07-09 | Pharmaceutical uses of NAB1 and NAB2 |
IS5788A IS5788A (en) | 1998-07-11 | 2000-12-22 | Pharmacological use of NAB1 and NAB2 |
ZA200100193A ZA200100193B (en) | 1998-07-11 | 2001-01-08 | Pharmaceutical uses of NAB1 and NAB2. |
NO20010166A NO20010166L (en) | 1998-07-11 | 2001-01-10 | Pharmaceutical applications of NAB1 and NAB2 |
HR20010025A HRP20010025A2 (en) | 1998-07-11 | 2001-01-11 | Pharmaceutical uses of nab1 and nab2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9814989.1A GB9814989D0 (en) | 1998-07-11 | 1998-07-11 | Gene therapy method |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9814989D0 true GB9814989D0 (en) | 1998-09-09 |
Family
ID=10835294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9814989.1A Ceased GB9814989D0 (en) | 1998-07-11 | 1998-07-11 | Gene therapy method |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB9814989D0 (en) |
ZA (1) | ZA200100193B (en) |
-
1998
- 1998-07-11 GB GBGB9814989.1A patent/GB9814989D0/en not_active Ceased
-
2001
- 2001-01-08 ZA ZA200100193A patent/ZA200100193B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200100193B (en) | 2002-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9622500D0 (en) | Therapeutic gene | |
GB9809414D0 (en) | Method | |
EP1077996A4 (en) | HUMAN EDG3sb GENE | |
IL139936A0 (en) | Gene therapy method | |
HUP0104046A3 (en) | Adenovirus-mediated gene therapy | |
GB9816556D0 (en) | Therapy | |
GB9809776D0 (en) | Method | |
GB9719161D0 (en) | New therapeutic method | |
GB9714841D0 (en) | Treatment method | |
GB9819764D0 (en) | Method | |
GB9924981D0 (en) | Gene therapy | |
GB9900009D0 (en) | Gene therapy | |
GB9815035D0 (en) | Gene therapy method | |
GB9814989D0 (en) | Gene therapy method | |
GB9819846D0 (en) | Gene therapy method | |
GB9819826D0 (en) | Gene therapy method | |
GB9811836D0 (en) | Gene therapy method | |
GB9706469D0 (en) | Genetic method | |
GB0406539D0 (en) | Gene therapy | |
GB9719189D0 (en) | New therapeutic method | |
GB9719176D0 (en) | New therapeutic method | |
GB9800683D0 (en) | Therapeutic method | |
GB9804285D0 (en) | Therapeutic method | |
GB9806039D0 (en) | Therapy | |
GB9826753D0 (en) | Genetic method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |